Brief: Innoviva Specialty Therapeutics Announces FDA Approval For Xacduro

Innoviva

23/05/2023 23:43

May 23 (Reuters) - Innoviva Inc  INVA.O :
    * INNOVIVA SPECIALTY THERAPEUTICS ANNOUNCES FDA APPROVAL FOR
XACDURO® (SULBACTAM FOR INJECTION; DURLOBACTAM FOR INJECTION),
CO-PACKAGED FOR INTRAVENOUS USE
    * WE ANTICIPATE THAT XACDURO WILL BE AVAILABLE TO PATIENTS
LATER
THIS YEAR

Source text for Eikon:  ID:nBw6vnwwQa 
Further company coverage:  INVA.O 

 ((Reuters.Briefs@thomsonreuters.com;;))